AAAAAA

   
Results: 1-11 |
Results: 11
Convergent synthesis of potent peptide inhibitors of the Grb2-SH2 domain by palladium catalyzed coupling of a terminal alkyne
Authors: Schoepfer, J Gay, B End, N Muller, E Scheffel, G Caravatti, G Furet, P
Citation: J. Schoepfer et al., Convergent synthesis of potent peptide inhibitors of the Grb2-SH2 domain by palladium catalyzed coupling of a terminal alkyne, BIOORG MED, 11(9), 2001, pp. 1201-1203
Investigations on the reactivity of fascaplysin - Part II - General stability considerations and products formed with nucleophiles
Authors: Fretz, H Ucci-Stoll, K Hug, P Schoepfer, J Lang, M
Citation: H. Fretz et al., Investigations on the reactivity of fascaplysin - Part II - General stability considerations and products formed with nucleophiles, HELV CHIM A, 84(4), 2001, pp. 867-873
Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways
Authors: Fretz, H Furet, P Garcia-Echeverria, C Rahuel, J Schoepfer, J
Citation: H. Fretz et al., Structure-based design of compounds inhibiting Grb2-SH2 mediated protein-protein interactions in signal transduction pathways, CUR PHARM D, 6(18), 2000, pp. 1777-1796
Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1
Authors: Furet, P Caravatti, G Denholm, AA Faessler, A Fretz, H Garcia-Echeverria, C Gay, B Irving, E Press, NJ Rahuel, J Schoepfer, J Walker, CV
Citation: P. Furet et al., Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1, BIOORG MED, 10(20), 2000, pp. 2337-2341
Investigations on the reactivity of fascaplysin - Part I - Aromatic electrophilic substitutions occur at position 9
Authors: Fretz, H Ucci-Stoll, K Hug, P Schoepfer, J Lang, M
Citation: H. Fretz et al., Investigations on the reactivity of fascaplysin - Part I - Aromatic electrophilic substitutions occur at position 9, HELV CHIM A, 83(11), 2000, pp. 3064-3068
Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product
Authors: Soni, R Muller, L Furet, P Schoepfer, J Stephan, C Zumstein-Mecker, S Fretz, H Chaudhuri, B
Citation: R. Soni et al., Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product, BIOC BIOP R, 275(3), 2000, pp. 877-884
Novel Cdk inhibitors restore TGF-beta sensitivity in Cdk4 overexpressing epithelial cells
Authors: Soni, R Fretz, H Muller, L Schoepfer, J Chaudhuri, B
Citation: R. Soni et al., Novel Cdk inhibitors restore TGF-beta sensitivity in Cdk4 overexpressing epithelial cells, BIOC BIOP R, 272(3), 2000, pp. 794-800
Highly potent inhibitors of the Grb2-SH2 domain
Authors: Schoepfer, J Fretz, H Gay, B Furet, P Garcia-Echeverria, C End, N Caravatti, G
Citation: J. Schoepfer et al., Highly potent inhibitors of the Grb2-SH2 domain, BIOORG MED, 9(2), 1999, pp. 221-226
Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic
Authors: Furet, P Garcia-Echeverria, C Gay, B Schoepfer, J Zeller, M Rahuel, J
Citation: P. Furet et al., Structure-based design, synthesis, and X-ray crystallography of a high-affinity antagonist of the Grb2-SH2 domain containing an asparagine mimetic, J MED CHEM, 42(13), 1999, pp. 2358-2363
Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility
Authors: Gay, B Suarez, S Weber, C Rahuel, J Fabbro, D Furet, P Caravatti, G Schoepfer, J
Citation: B. Gay et al., Effect of potent and selective inhibitors of the Grb2 SH2 domain on cell motility, J BIOL CHEM, 274(33), 1999, pp. 23311-23315
Selective GRB2 SH2 inhibitors as anti-Ras therapy
Authors: Gay, B Suarez, S Caravatti, G Furet, P Meyer, T Schoepfer, J
Citation: B. Gay et al., Selective GRB2 SH2 inhibitors as anti-Ras therapy, INT J CANC, 83(2), 1999, pp. 235-241
Risultati: 1-11 |